BioPharma Credit PLC
BOPCF
$0.96
$0.011.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 5.14% | 9.08% | 13.42% | 11.98% | 10.53% |
| Total Revenue | 5.14% | 9.08% | 13.42% | 11.98% | 10.53% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 5.14% | 9.08% | 13.42% | 11.98% | 10.53% |
| SG&A Expenses | 1.13% | 9.24% | 17.60% | 9.55% | 1.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -203.85% | -200.46% | -195.40% | -46.59% | 12,900.00% |
| Total Operating Expenses | 0.17% | 8.41% | 16.91% | 9.46% | 2.09% |
| Operating Income | 6.28% | 9.24% | 12.56% | 12.60% | 12.65% |
| Income Before Tax | 6.31% | 9.27% | 12.58% | 12.62% | 12.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 6.31% | 9.27% | 12.58% | 12.62% | 12.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.31% | 9.27% | 12.58% | 12.62% | 12.66% |
| EBIT | 6.28% | 9.24% | 12.56% | 12.60% | 12.65% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 14.26% | 17.74% | 21.76% | 21.18% | 20.58% |
| Normalized Basic EPS | 14.47% | 17.90% | 21.85% | 21.21% | 20.54% |
| EPS Diluted | 14.26% | 17.74% | 21.76% | 21.18% | 20.58% |
| Normalized Diluted EPS | 14.47% | 17.90% | 21.85% | 21.21% | 20.54% |
| Average Basic Shares Outstanding | -6.77% | -7.32% | -7.85% | -7.24% | -6.65% |
| Average Diluted Shares Outstanding | -6.77% | -7.32% | -7.85% | -7.24% | -6.65% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.31% | -0.44% | -0.56% | -0.20% | 0.40% |